CytoDyn files protocol with FDA for 'long-hauler' coronavirus patients in Phase 2 leronlimab trial  ProactiveView Full coverage on Google News
Rapid Enrollment Expected, As Many People Have Already Volunteered VANCOUVER, Washington, Nov. 17, 2020 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY),...Rapid Enrollment Expected, As Many People Have Already Volunteered VANCOUVER, Washington, Nov. 17, 2020 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY),...

CytoDyn Files Protocol with U.S. FDA for Phase 2 Clinical Trial for COVID-19 Patients with Long-Hauler Symptoms OTC Markets:CYDY

520 Origin Error